← Back to Search

Web-Based Support Program for Caregivers of Lung Cancer Patients (CONNECT Trial)

N/A
Waitlist Available
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
Patient must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
Must not have
Patient must be unable to read and English and not willing to have someone read surveys for them
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at completion of practice intervention activities, an average of 18 months
Awards & highlights

Summary

"This trial is testing a new online resource called CONNECT for caregivers of patients with advanced lung cancer. The resource aims to connect caregivers with tailored support services. Caregivers play a crucial role in caring for

Who is the study for?
This trial is for adult caregivers providing unpaid care to someone with stage II-IV lung cancer. Caregivers must be able to use the internet and have a phone for navigation sessions. The patient must have started treatment with at least 9 weeks left, and both caregiver and patient need an ECOG status of 0-2.
What is being tested?
The study tests a web-based program called CONNECT that matches caregivers of lung cancer patients with supportive resources. It includes personalized support lists and caregiver navigation sessions to help manage their responsibilities.
What are the potential side effects?
Since this trial involves non-medical interventions like online support systems and information provision, there are no direct medical side effects associated with drugs or procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I spend more than half of my day out of bed.
Select...
I am 18 years old or older.
Select...
My lung cancer is at stage II, III, or IV.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot read English and do not want help with reading surveys.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at conclusion of practice intervention activities, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at conclusion of practice intervention activities, an average of 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Caregiver retention at 12 weeks
Secondary study objectives
Average time (minutes) needed for training for Local Practice Referral Coordinator
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
+13 more
Other study objectives
Patient accrual rate
Patient participation rate
Patient retention at 12 weeks
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Group 3 (CONNECT, personalized list, and navigation)Experimental Treatment3 Interventions
Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs.
Group II: Group 1 (Standard care followed by generic resource list)Active Control1 Intervention
Caregivers receive standard care and are then given a generic resource list at week 24.
Group III: Group 2 (Generic resource list)Active Control1 Intervention
Caregiver receive a generic resource list at the start of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,467 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,760 Total Patients Enrolled
Kathryn Weaver, PhDStudy ChairWake Forest University Health Sciences
2 Previous Clinical Trials
230 Total Patients Enrolled
~160 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top